Breaking News
Russia Hits Ukraine Power Plant Despite "Energy Ceasefire"
Multi-material insulation delivers up to 10,000 x the stiffness
Trump Just Started The Debt Spiral
Look up...Top Tech News
Anduril's plan to save US sub edge from China's undersea surge
Researchers Develop AI 'Mind-Reading' Tool That Reconstructs What Your Eyes See
Video: Dexterous robot hand learns the delicate art of silk embroidery
The computer that can read your mind:
Seven apps. One craft
SHOCK CASE REPORT: Advanced Alzheimer's Patient Regains Speech, Memory, Mobility...
Most artificial limbs rely on silicone or plastic to mimic human hands.
Flying cell tower beams phone signal to Japan from 10 miles up
Chinese Commercial Reactor Achieves Nuclear Fusion with Clean Hydrogen-Boron Fuel
Palmer Luckey: Autonomous Weapons Are Ancient and Why Anduril Won't Build Humanoids | EP #295
Tumor-Destroying Sound Waves Treatment Coming to a Hospital Near You For Liver Cancer
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.